Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director
|
Silo Pharma, Inc. (UCUT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/26/2023 |
4
| Ryweck Daniel E. (CFO) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Bought 1,000 shares
@ $2.1264, valued at
$2.1k
|
|
05/18/2023 |
4
| Weisblum Eric (CEO and President) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Bought 2,500 shares
@ $2.06, valued at
$5.2k
Bought 500 shares
@ $2.107, valued at
$1.1k
|
|
12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/21/2022 |
4
| Weisblum Eric (CEO, CFO and President) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Bought 13,080 shares
@ $0.1147, valued at
$1.5k
|
|
01/05/2022 |
4/A
| Linsley Wayne (Director) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Granted 171,233 options to buy
@ $0.146, valued at
$25k
|
|
01/03/2022 |
4
| Linsley Wayne (Director) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Granted 171,233 options to buy
@ $0.146, valued at
$25k
|
|
01/03/2022 |
4
| Munoz Kevin (Director) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Granted 171,233 options to buy
@ $0.146, valued at
$25k
|
|
12/15/2021 |
4
| Weisblum Eric (CEO) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Bought 5,000 shares
@ $0.1554, valued at
$777 Bought 17,500 shares
@ $0.1377, valued at
$2.4k
|
|
05/17/2021 |
4/A
| Weisblum Eric (CEO, CFO and President) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Granted 7,630,949 shares
@ $0 |
|
05/17/2021 |
4
| Weisblum Eric (CEO, CFO and President) has filed a Form 4 on Silo Pharma, Inc.
Txns:
| Bought 57,714 shares
@ $0.002, valued at
$115.4 Bought 200 shares
@ $0.38, valued at
$76 Bought 200 shares
@ $0.45, valued at
$90 Granted 100,000 options to buy
@ $0.0001, valued at
$10 Granted 100,000 options to buy
@ $0.0001, valued at
$10 |
|
02/25/2021 |
3
| Linsley Wayne (Director) has filed a Form 3 on Silo Pharma, Inc. |
02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/30/2020 |
4
| Weisblum Eric (CEO) has filed a Form 4 on Uppercut Brands, Inc.
Txns:
| Granted 7,630,949 shares
@ $0 |
|
01/07/2013 |
3
| Schlossberg Melvin (PRESIDENT, CEO & SECRETARY) has filed a Form 3 on Gold Swap Inc |
01/02/2013 |
3
| Ptalis Donald (CFO) has filed a Form 3 on Gold Swap Inc |
12/27/2012 |
3
| MATS VADIM (VP of Business Development) has filed a Form 3 on Gold Swap Inc |
12/27/2012 |
3
| WHALEHAVEN CAPITAL FUND LTD (10% Owner) has filed a Form 3 on Gold Swap Inc |
|
|